Loading clinical trials...
Loading clinical trials...
The Copper Metabolism MURR1 Domain 7 (COMMD7) Gene Expression in Acute Lymphoblastic Leukemia
Conditions
Interventions
Reverse transcription-quantitative polymerase chain reaction (RT-qPCR).
Start Date
November 1, 2022
Primary Completion Date
April 1, 2024
Completion Date
November 1, 2024
Last Updated
October 24, 2022
NCT05691465
NCT06085586
NCT07336732
NCT07190248
NCT07485114
NCT05692635
Lead Sponsor
Assiut University
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions